Your browser doesn't support javascript.
loading
CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.
Koofhethile, Catherine K; Ndhlovu, Zaza M; Thobakgale-Tshabalala, Christina; Prado, Julia G; Ismail, Nasreen; Mncube, Zenele; Mkhize, Lungile; van der Stok, Mary; Yende, Nonhlanhla; Walker, Bruce D; Goulder, Philip J R; Ndung'u, Thumbi.
Affiliation
  • Koofhethile CK; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
  • Ndhlovu ZM; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
  • Thobakgale-Tshabalala C; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, Massachusetts, USA.
  • Prado JG; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
  • Ismail N; AIDS Research Institute IrsiCaixa, Hospital Universitari Germans TriasiPujol, Barcelona, Spain.
  • Mncube Z; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
  • Mkhize L; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
  • van der Stok M; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
  • Yende N; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
  • Walker BD; Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.
  • Goulder PJR; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
  • Ndung'u T; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, Massachusetts, USA.
J Virol ; 90(15): 6818-6831, 2016 08 01.
Article in En | MEDLINE | ID: mdl-27194762

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 Database: MEDLINE Main subject: Viremia / T-Lymphocytes, Cytotoxic / Histocompatibility Antigens Class I / HIV Infections / HIV-1 / CD8-Positive T-Lymphocytes Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Humans Language: En Journal: J Virol Year: 2016 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 Database: MEDLINE Main subject: Viremia / T-Lymphocytes, Cytotoxic / Histocompatibility Antigens Class I / HIV Infections / HIV-1 / CD8-Positive T-Lymphocytes Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Humans Language: En Journal: J Virol Year: 2016 Document type: Article